Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-γ expression in splenic T cells

This publication has 63 references indexed in Scilit:

• Long-term culture of islets abrogates cytokine-induced or lymphocyte-induced increase of antigen expression on ?? cells1
  Transplantation, 2002
• Thiazolidinediones: metabolic actions in vitro
  Diabetologia, 2002
• Thiazolidinediones for the prevention of diabetes in the non‐obese diabetic (NOD) mouse: implications for human type 1 diabetes
  Diabetes/Metabolism Research and Reviews, 2002
• Glitazones: clinical effects and molecular mechanisms
  Annals of Medicine, 2002
• Dual Function of Troglitazone in ICAM-1 Gene Expression in Human Vascular Endothelium
  Biochemical and Biophysical Research Communications, 2001
• Thiazolidinediones (PPARγ agonists) but not PPAR α agonists increase IRS‐2 gene expression in 3T3‐L1 and human adipocytes¹
  The FASEB Journal, 2000
• Cellular and molecular roles of β cell autoantigens, macrophages and T cells in the pathogenesis of autoimmune diabetes
  Archives of Pharmacal Research, 1999
• In vivo microscopy of murine islets of Langerhans: increased adhesion of transferred lymphocytes to islets depends on macrophage‐derived cytokines in a model of organ‐specific insulitis
  Immunology, 1999
• Troglitazone Exhibits Immunomodulatory Activity on the Cytokine Production of Activated Human Lymphocytes
  Hormone and Metabolic Research, 1999
• Insulin Therapy of Prediabetes Suppresses TH1 Associated Gene Expression in BB Rat Pancreas
  Autoimmunity, 1997